According to Federal Trade Commission Chairwoman Edith Ramirez, the healthcare sector will "remain a top agency priority."

The Complaint alleged that Carolinas Healthcare insisted on contract provisions with payors that limited or prohibited steering to lower-cost providers.

A popular weapon used to contain health care expenditures is the creation by payors and employers of tiered provider networks, which by differentiated co-pays attempt to steer insureds to less expensive choices.

A New Jersey district court recently denied a motion to dismiss Talone, et. al. v. The American Osteopathic Association, an antitrust class action.

Connecticut requires prior notification of any transaction that will result in a material change of the business or corporate structure of a medical group practice.

A federal district court in New Jersey found that Mylan Pharmaceuticals, Inc. alleged facts sufficient to plead an antitrust claim under Section 2 of the Sherman Act against defendant, Celgene Corporation.

Foley & Lardner LLP partner Diane Hazel authored the Medical Economics article, "Private equity investments in physician practices draw regulatory scrutiny," exploring the growing concern among...

The DOJ Antitrust Division recently announced plans to hold a series of public roundtable discussions to analyze the relationship between competition and regulation, and its implications for antitrust enforcement policy.

In an opinion written by Judge Posner, the Seventh Circuit on Friday, June 9, 2017...

On February 24 and 25, 2015, the FTC and DOJ will host the second public workshop in their series entitled, "Examining Health Care Competition."

The Federal Trade Commission continues to analyze relevant products that have not yet been introduced into the market in its merger analysis.

The United States Court of Appeals for the Ninth Circuit recently upheld a district court’s finding that a consummated hospital-physician group merger violated Section 7 of the Clayton Act.

In June, an antitrust suit brought by plaintiff ambulatory surgery centers ("ASCs") against a health system, health insurers, and a trade association survived a motion to dismiss.

Antitrust Associate Amanda Hamilton published an article in FDLI's Update Magazine for the January-February 2018 Issue entitled "Navigating an FTC Drug Pricing Investigation

In an April 22, 2015 letter to the New York State Department of Health, the Federal Trade Commission cautioned that part of the state’s Medicaid reform program may sanction anticompetitive behavior.

The health care industry remains an enforcement priority for the Federal Trade Commission ("FTC").

The Third Circuit affirmed a lower court's dismissal of a suit filed by a hospital alleging an illegal exclusive dealing arrangement by a competing hospital and physician group.

As the healthcare sector continues to grapple with the COVID-19 pandemic, it will face increased antitrust scrutiny from the Biden administration, with the Federal Trade Commission (the "FTC")...

In the first episode of this two-part MoFo Perspectives podcast, Morrison Foerster Global Antitrust attorneys Bonnie Lau and Joseph Charles Folio speak with Kevin Mullen of the Government Contracts and Public Procurement Group, ...

Hunton Andrews Kurth LLP partner Lorie Masters, partnering with insurance broker Marsh and others, analyzed the often complex issues raised by the insurance coverage actions posed by actions